HAEM4:Hairy Cell Leukemia: Difference between revisions
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 11: | Line 11: | ||
==Cancer Category/Type== | ==Cancer Category/Type== | ||
*[[Mature B-Cell Neoplasms|Mature B-Cell Neoplasm]] | *[[HAEM4:Mature B-Cell Neoplasms|Mature B-Cell Neoplasm]] | ||
==Cancer Sub-Classification / Subtype== | ==Cancer Sub-Classification / Subtype== | ||
| Line 174: | Line 174: | ||
<sup>‡</sup>Specific mutations in these genes can be found in [https://www.cbioportal.org/ cBioPortal] and [https://cancer.sanger.ac.uk/cosmic COSMIC]. | <sup>‡</sup>Specific mutations in these genes can be found in [https://www.cbioportal.org/ cBioPortal] and [https://cancer.sanger.ac.uk/cosmic COSMIC]. | ||
'''*'''The WHO states that BRAF p.Val600Glu is detected in virtually all cases and notes that the classification of B-cell leukemias that are immunophenotypically and morphologically classified as HCL but lack BRAF activating mutations (but instead have MAP2K1 activating mutations and use the IGHV4-34 gene segment) is uncertain. These seem to be more similar molecularly and clinically to [[ | '''*'''The WHO states that BRAF p.Val600Glu is detected in virtually all cases and notes that the classification of B-cell leukemias that are immunophenotypically and morphologically classified as HCL but lack BRAF activating mutations (but instead have MAP2K1 activating mutations and use the IGHV4-34 gene segment) is uncertain. These seem to be more similar molecularly and clinically to [[HAEM5:Splenic B-cell lymphoma/leukaemia with prominent nucleoli|HCLv]]. | ||
*BRAF and MAP2K1 activating mutations are mutually exclusive | *BRAF and MAP2K1 activating mutations are mutually exclusive | ||
| Line 229: | Line 229: | ||
|BRAF p.Val600Glu | |BRAF p.Val600Glu | ||
|Diagnostic | |Diagnostic | ||
|May be useful when immunophenotype is equivocal; Excludes [[ | |May be useful when immunophenotype is equivocal; Excludes [[HAEM5:Splenic B-cell lymphoma/leukaemia with prominent nucleoli|HCLv]] | ||
|- | |- | ||
|MAP2K1 | |MAP2K1 | ||
| Line 257: | Line 257: | ||
==Links== | ==Links== | ||
*[[ | *[[HAEM5:Splenic B-cell lymphoma/leukaemia with prominent nucleoli]] | ||
*[[Splenic | *[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma]] | ||
==References== | ==References== | ||